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Background: The European Academy of Allergy and Clinical Immunology is in the process of developing its
Guideline for Food Allergy and Anaphylaxis, and this systematic review is one of seven inter-linked evidence
syntheses that are being undertaken in order to provide a state-of-the-art synopsis of the current evidence base in
relation to epidemiology, prevention, diagnosis and clinical management, and impact on quality of life, which will
be used to inform clinical recommendations. The aim of this systematic review will be to determine which
validated instruments can be employed to enable assessment of the impact of, and investigations and
interventions for, food allergy on health-related quality of life.
Methods: Seven bibliographic databases were searched from their inception to September 30, 2012 for
disease-specific HRQL questionnaires that were specifically designed for use with patients/carers and any articles
relating to the description, development and/or the validation of the above identified HRQLs. There were no
language or geographic restrictions. We will assess the development of the instruments identified and their
performance properties including: validity; generalizability; responsiveness; managing missing data; how variation in
patient demography was managed; and cross-cultural and linguistic adaptation, using a previously reported quality
assessment tool.
Discussion: Using appropriately developed and validated instruments is critical to the accurate evaluation of HRQL
in people with food allergy. This review will systematically appraise the evidence on the subject and help to
identify any gaps.
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The umbrella term ‘food hypersensitivity’ can be used to
describe any ‘adverse reaction to food’ [1]. The term ‘food
allergy’ refers to the subgroup of food-triggered reactions
in which immunologic mechanisms have been implicated,
whether IgE-mediated, non-IgE-mediated, or involving a
combination of IgE- and non-IgE-mediated etiologies [2].
All other reactions to food that were in the past some-
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reproduction in any medium, provided the orallergic food hypersensitivity reactions and are outside the
focus of this systematic review. Coeliac disease is an
important non-IgE mediated condition but as it has
distinct symptoms and prognosis different from atopic
conditions it will be excluded from this review [3].
IgE-mediated reactions can, for example, manifest as
angioedema, urticaria, atopic eczema/dermatitis, oral
allergy syndrome and anaphylaxis. Non-IgE-mediated
immunologic reactions result from activation of other
immunologic pathways (e.g. T-cell mediated) and can
manifest as atopic eczema/dermatitis, gastro-esophageal
reflux disease, food protein-induced enterocolitis, procto-
colitis, and enteropathy syndromes. The contemporaryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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entities with different pathophysiologies [3], resulting from
exposure to different foods. This review will consider only
instruments developed for IgE-mediated food allergy.
There are a number of concerns regarding outcome
measures in food allergy: the vast array of outcome
measures used in research settings; their specificity, i.e.
related to one condition rather than the whole person;
gaps in relation to allergic conditions other than asthma,
eczema and rhinitis; and the fact that they do not always
include issues that are pertinent to patients [4]. Living
with a food allergy is more difficult than is generally
appreciated. Management is focused on the avoidance of
food causing allergic reactions, which places a psycho-
logical burden on patients that is associated with high
stress levels and anxiety. In some cases, this can have a
considerable impact on their daily lives. Quality of life as
defined by the World Health Organization (WHO) is
“the individual's perception of their position in life in the
context of the culture and value systems in which they
live and in relation to their goals, expectations, standards
and concerns” [5]. The importance of measuring quality
of life in patients is that such measurement allows for
the estimation of the impact of the disease from a
patient perspective, as it is possible that two individuals
with clinically similar disease severity may assess impair-
ment in their everyday lives to different degrees [6].
Therefore quality of life measurements are being utilised
by clinicians to gain insights into specific problems
patients face and the effectiveness of interventions to
enhance patient’s quality of life [7].
Health-related quality of life can be measured using
generic or disease specific questionnaires. Useful attri-
butes of generic quality of life questionnaires are that
they allow comparison between different diseases as well
as being sensitive to co-morbidities. However, associated
limitations of generic instruments include the fact that
they are less sensitive than disease-specific question-
naires, hence potentially important differences or
changes may be missed. This is particularly seen in the
context of food allergy, where unless individuals are
exposed to the specific food, patients will have no symp-
toms or problems other than the need to avoid certain
foods [8]. The disease-specific questionnaires that have
been developed are significantly more sensitive in measu-
ring the response to interventions or future treatments, as
well as estimating the general burden of food allergy [9].
The European Academy of Allergy and Clinical Immu-
nology (EAACI) is in the process of developing the EAACI
Guideline for Food Allergy and Anaphylaxis, and this
systematic review is one of seven inter-linked evidence
syntheses that are being undertaken in order to provide a
state-of-the-art synopsis of the current evidence base in
relation to epidemiology, prevention, diagnosis andclinical management, and impact on quality of life, which
will be used to inform clinical recommendations.
Aims
The aims of this systematic review will be to determine
which validated instruments can be employed to enable
assessment of the impact of, and investigations and inter-
ventions for, food allergy on health-related quality of life.
Methods
Search strategy
A sensitive search strategy will be designed to retrieve
all articles combining the concepts of food allergy and
quality of life, and patient reported outcomes from elec-
tronic bibliographic databases. We have conceptualised
the search to incorporate three elements, as shown in
Figure 1: Conceptualisation of systematic review of
disease-specific health-related quality of life (HRQL)
tools for food allergy.
We have adapted a search filter from York University
Centre for Reviews and Dissemination to retrieve quality
of life and patient-reported outcome material. We will
search the following databases:
 MEDLINE (OVID)
 Embase (OVID)
 CINAHL (Ebscohost)
 ISI Web of Science (Thomson Web of Knowledge)
The search strategy has been devised on OVID
MEDLINE and then adapted for the other databases
(see Additional file 1 for full search strategies). In all
cases, the databases will be searched from 1990 to 30
September 2012. All references will be imported into an
EndNote Library and tagged with the name of the data-
base. Searches will be limited to literature from 1990
onwards; this limit is based on the first publication of
key allergy HRQLs such as the Rhinoconjunctivitis
Quality of Life Questionnaire and Asthma Quality of
Life Questionnaire [10,11]. Additional references will be
located through searching the references cited by the
identified studies, and unpublished work and research in
progress will be identified through discussion with
experts in the field. We will invite experts who are active
in the field from a range of disciplines and locations to
comment on our search strategy and the list of included
studies. There are no language restrictions and, where
possible, all literature will be translated.
Inclusion criteria
 The disease-specific HRQL questionnaire must be
specifically designed for use in patients/carers with
food allergy
Figure 1 Conceptualisation of systematic review of disease-specific health-related quality of life (HRQL) tools for food allergy.
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and/or the validation of the above identified HRQLs.
Exclusion criteria
 Reviews, discussion papers, non-research letters and
editorials
 Case studies and case series
 Animal studies.
Study selection
The titles will be checked independently by two
reviewers according to the above selection criteria and
categorised as: included, not included and unsure. For
those papers in the unsure category, we will retrieve the
abstract and re-categorise as above. Any discrepancies
will be resolved by consensus and, if necessary, a third
reviewer will be consulted to arbitrate. Full text copies
of potentially relevant studies will be obtained and their
eligibility for inclusion independently assessed. Studies
that do not fulfil all of the inclusion criteria will be
excluded.
Quality assessment strategy
We plan to assess the development of the instruments
identified and their performance properties, including
validity, generalisability, responsiveness, managing missing
data, how variation in patient demography is managed,
cross-cultural and linguistic adaptation using a previously
reported quality assessment tool [12]. Assessment of
validity will focus on identification of appropriate inde-
pendent measures and their correlation with partial or
total instrument scores. A team of researchers will inde-
pendently assess the articles against the defined criteriaand any discrepancies will be resolved by consensus and,
if necessary, a third reviewer will be consulted.
Analysis, data synthesis and reporting
Data will be independently extracted onto a customised
data extraction sheet by two reviewers, and any discre-
pancies will be resolved by discussion or, if agreement
cannot be reached, by arbitration by a third reviewer.
A descriptive summary with data tables will be
produced to summarise the literature. If clinically and
statistically appropriate, meta-analysis using either fixed-
effect or random-effects modelling will be undertaken
using methods suggested by Agresti and Coull [13]. A
narrative synthesis of the data will also be undertaken.
This review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
and has registration number CRD42013003710 allocated
to it. The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist will be
used to guide the reporting of the systematic review [14].
Discussion
Food allergy has a profound impact on children, ado-
lescents and their families. In particular, the constant
vigilance needed to avoid allergens and the daily manage-
ment of food allergy impacts on daily family activities and
social events. The main strengths of this work include the
development of a detailed systematic review protocol, a
comprehensive search strategy and a detailed critical
appraisal of the identified instruments. The limitations of
this work include the fact that our focus will be on IgE-
mediated food allergy, whereas we know that non-IgE-
mediated and mixed IgE/non-IgE-mediated food allergy
is common (particularly in young children) and can
have a profound impact on QOL. This decision reflects
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developed; this therefore reflects an important out-
standing research need.
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